These findings were interpreted to indicate that pathogenic TH17 cells are dependent upon Stat3 signaling and that inhibition of this signaling pathway results in mitigation of autoimmune disease progression (Harris et al., 2007). This evidence concerns the gene STAT3 and autoimmune disease.